Mitsu Chem Plast Projects Strong FY27 Recovery With New Verticals

Mitsu Chem Plast has unveiled its fiscal year 2027 outlook, forecasting a significant 30% increase in both revenue and volume. This projected growth is expected to drive the company towards its goal of achieving INR 1,000 crore in annual revenue by fiscal year 2028. The guidance was shared following a Q4 FY26 earnings call where the company highlighted improved operating efficiency and strategic expansion into new business areas.

New Ventures Drive Expansion

The company is entering the Intermediate Bulk Container (IBC) market with a new automated plant commissioned at its Khalapur facility. Simultaneously, Mitsu Chem Plast is expanding its 'Furnastra' healthcare furniture business, which is being positioned as a key growth and margin driver due to increasing domestic and international acceptance. The company's total installed capacity across its Maharashtra facilities now exceeds 29,900 metric tons annually.

Strategic Pivot to Higher Margins

This strategic pivot aims to deliver a strong recovery in FY27 after what management described as a "muted" FY26. By focusing on higher-margin segments like healthcare furniture and IBCs, the company seeks to boost profitability. Achieving the INR 1,000 crore revenue target by FY28 would represent a considerable scale-up for Mitsu Chem Plast, with healthcare and infrastructure revenue targeted to contribute 15-20% by FY28.

Key Risks to Monitor

Investors should note several key risks. Raw material prices, particularly for HDPE, have shown significant volatility, with previous increases of up to 40%. This fluctuation can lead to inventory losses if prices drop or unexpected cost increases. Additionally, the company typically operates with only one month of order visibility, making consistent planning a challenge. Management also acknowledged some growth plans are "a little delayed," with a current focus on bottom-line improvement over potentially unprofitable sales.

Competitive Landscape

Mitsu Chem Plast operates in a competitive landscape. Key players include Supreme Industries Ltd., India's largest plastic processor with a broad portfolio. Xpro India Ltd. is a direct competitor in the IBC segment, while Manjushree Technopack Ltd. is another significant competitor, particularly in rigid plastic packaging for various consumer sectors.

Outlook and Tracking Points

Looking ahead, the company is targeting sustainable EBITDA margins of at least 10%, with a minimum utilization of 40-45% of its capacity. The new IBC plant is expected to commence operations in Q2 FY27. Investors will be closely monitoring the ramp-up of the IBC plant, the growth trajectory of the 'Furnastra' brand, HDPE price trends, and management's execution of these expansion plans.